Intelligent Bio Solutions (INBS)

Intelligent Bio Solutions (INBS) Stock Price & Analysis


INBS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.16 - $44.88
Previous Close$2.31
Average Volume (3M)89.75K
Market Cap
Enterprise Value$7.02M
Total Cash (Recent Filing)$1.12M
Total Debt (Recent Filing)$1.08M
Price to Earnings (P/E)
Nov 06, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.79
Shares Outstanding3,117,049
10 Day Avg. Volume78,933
30 Day Avg. Volume89,752
Standard Deviation0.64
Financial Highlights & Ratios
Price to Book (P/B)-4.76
Price to Sales (P/S)5.72
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.27
Enterprise Value/Gross Profit21.49
Enterprise Value/Ebitda-0.58
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Ownership Overview

39.93% Insiders
25.08% Other Institutional Investors
34.74% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products


What was Intelligent Bio Solutions’s price range in the past 12 months?
Intelligent Bio Solutions lowest stock price was $2.16 and its highest was $44.88 in the past 12 months.
    What is Intelligent Bio Solutions’s market cap?
    Currently, no data Available
    When is Intelligent Bio Solutions’s upcoming earnings report date?
    Intelligent Bio Solutions’s upcoming earnings report date is Nov 06, 2024 which is in 165 days.
      How were Intelligent Bio Solutions’s earnings last quarter?
      Intelligent Bio Solutions released its earnings results on May 08, 2024. The company reported -$1.43 earnings per share for the quarter, missing the consensus estimate of -$0.87 by -$0.56.
        Is Intelligent Bio Solutions overvalued?
        According to Wall Street analysts Intelligent Bio Solutions’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Intelligent Bio Solutions pay dividends?
          Intelligent Bio Solutions does not currently pay dividends.
          What is Intelligent Bio Solutions’s EPS estimate?
          Intelligent Bio Solutions’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Intelligent Bio Solutions have?
          Intelligent Bio Solutions has 3,117,049 shares outstanding.
            What happened to Intelligent Bio Solutions’s price movement after its last earnings report?
            Intelligent Bio Solutions reported an EPS of -$1.43 in its last earnings report, missing expectations of -$0.87. Following the earnings report the stock price went down -13.495%.
              Which hedge fund is a major shareholder of Intelligent Bio Solutions?
              Among the largest hedge funds holding Intelligent Bio Solutions’s share is Gotham Asset Management LLC. It holds Intelligent Bio Solutions’s shares valued at N/A.

                Company Description

                Intelligent Bio Solutions

                Glucose Biosensor Systems (Greater China) Holdings Inc is a United States based company engaged in manufacturing of Saliva Glucose Biosensor (SGB). SGB uses saliva to measure glucose non-invasively. The Saliva Glucose Test consists of the SGB which is a single use disposable saliva biosensor and the software app that interfaces the SGB with its digital information system.
                Similar Stocks
                Price & Change
                Aptose Biosciences
                Allogene Therapeutics
                Axonics Modulation Technologies
                Popular Stocks
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis